Strain SummaryC3H/HeNCr
Strain Name |
C3H/HeNCr |
Strain Type(s) |
inbred |
Strain Synonym(s) |
C3H • C3H/He • C3H/HeNCr MTV- • C3H/HeNCrMTV- |
Strain Links |
• Festing's List of Inbred Strains |
Frequency | ||||||||
---|---|---|---|---|---|---|---|---|
Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
Adipose tissue lipoma | Kidney |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Adipose tissue lipoma | Intestine - Small Intestine |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Adrenal gland - Cortex adenoma | Adrenal gland - Cortex |
8.3 |
37.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
30 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | sodium arsenite |
0 - 4.8 |
65 - 71 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Cortex adenoma | Adrenal gland - Cortex | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.5 - 9.5 |
57 - 65 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex |
0 |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.2 |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex | sodium arsenite |
0 |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Cortex carcinoma | Adrenal gland - Cortex | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Adrenal gland - Medulla pheochromocytoma | Adrenal gland - Medulla | sodium arsenite |
4.8 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Blood vessel hemangioma | Liver |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Blood vessel hemangioma | Uterus |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Ovary |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Leg |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Oviduct |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Heart |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Kidney |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Intestine - Small Intestine |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangioma | Spleen |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Blood vessel hemangiosarcoma | Liver |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Connective tissue - Fibroblast fibrosarcoma | Preputial gland (male) |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Connective tissue myxoma | Uterus - Cervix |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Eye - Harderian gland adenoma | Eye - Harderian gland |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Eye - Harderian gland carcinoma | Eye - Harderian gland |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Kidney lesion | Kidney | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
6 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Leukocyte lymphohematopoietic neoplasm | Leukocyte | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
32 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Leukocyte lymphoma | Leukocyte | beta-naphthoflavone (betaNF) |
6.3 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Leukocyte lymphoma | Leukocyte |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Liver hepatoblastoma | Liver | sodium arsenite |
4.8 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Liver hepatocellular adenoma | Liver | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) ⋅ beta-naphthoflavone (betaNF) |
6.9 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Liver hepatocellular adenoma | Liver |
6.7 - 8.3 |
42 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 ⋅ Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Liver hepatocellular adenoma | Liver | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
18 - 29 |
52 - 76 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular adenoma | Liver | sodium arsenite |
13 - 14 |
52 - 90 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular adenoma | Liver | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
8.3 |
35 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular carcinoma | Liver | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
3.0 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Liver hepatocellular carcinoma | Liver | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
9.1 - 19 |
26 - 33 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular carcinoma | Liver | sodium arsenite |
4.8 - 13 |
35 - 48 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular carcinoma | Liver |
4.2 |
12.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Liver hepatocellular carcinoma | Liver | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
8.3 |
8.7 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular tumor | Liver | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
27 - 38 |
65 - 86 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular tumor | Liver | sodium arsenite |
19 - 26 |
61 - 90 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular tumor | Liver | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
12.5 |
39 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Liver hepatocellular tumor | Liver |
12.5 |
50 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Liver lesion | Liver | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
82 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Liver lesion | Liver |
66 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
|||||
Lung adenoma | Lung |
4.2 |
17 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Lung adenoma | Lung | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.2 |
8.7 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung adenoma | Lung | sodium arsenite |
8.7 - 9.5 |
24 - 26 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung adenoma | Lung | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
9.1 - 29 |
24 - 43 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung carcinoma | Lung |
0 |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Lung carcinoma | Lung | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.2 |
4.3 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung carcinoma | Lung | sodium arsenite |
0 |
4.3 - 4.8 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung carcinoma | Lung | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 - 9.1 |
0 - 9.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung lesion | Lung | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
74 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Lung lesion | Lung |
7 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
|||||
Lung tumor | Lung | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
79 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Lung tumor | Lung | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) ⋅ beta-naphthoflavone (betaNF) |
86 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Lung tumor | Lung | beta-naphthoflavone (betaNF) |
6.3 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Lung tumor | Lung |
4.2 - 6.7 |
17 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 ⋅ Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Lung tumor | Lung | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
8.3 |
13 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung tumor | Lung | sodium arsenite |
8.7 - 9.5 |
29 - 30 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Lung tumor | Lung | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
18 - 29 |
33 - 43 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
Mammary gland adenocarcinoma | Mammary gland |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Melanocyte melanoma | Uterus - Cervix |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Mesodermal cell/mesoblast sarcoma | Skin | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Mesodermal cell/mesoblast sarcoma | Skin |
8.3 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Mesodermal cell/mesoblast sarcoma | Leg |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Mesodermal cell/mesoblast sarcoma | Liver |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Mesodermal cell/mesoblast sarcoma | Peritoneum |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Mesodermal cell/mesoblast squamous cell sarcoma | Forestomach |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Muscle - Smooth leiomyoma | Uterus |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Muscle - Smooth leiomyosarcoma | Muscle - Smooth | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) ⋅ beta-naphthoflavone (betaNF) |
3.4 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Ovary - Germ cell teratoma | Ovary - Germ cell | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) ⋅ beta-naphthoflavone (betaNF) |
3.4 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Ovary adenoma | Ovary | sodium arsenite |
17 - 19 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary adenoma | Ovary |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Ovary adenoma | Ovary | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary adenoma | Ovary | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
19 - 23 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary carcinoma | Ovary |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Ovary carcinoma | Ovary | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary carcinoma | Ovary | sodium arsenite |
0 - 4.3 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary carcinoma | Ovary | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary tumor | Ovary | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) ⋅ beta-naphthoflavone (betaNF) |
3.4 |
References: Anderson LM, Cancer Lett 1990 Jul 16;52(2):91-4 |
||||
Ovary tumor | Ovary |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Ovary tumor | Ovary | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary tumor | Ovary | sodium arsenite |
19 - 22 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Ovary tumor | Ovary | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
19 - 23 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Oviduct adenoma | Oviduct | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Oviduct hyperplasia | Oviduct |
12.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Oviduct hyperplasia | Oviduct | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
12.5 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Oviduct hyperplasia | Oviduct | sodium arsenite |
35 - 48 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Oviduct hyperplasia | Oviduct | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
32 - 43 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
PNS - Schwann cell schwannoma | Nerve | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
5.5 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
PNS - Schwann cell schwannoma | Nerve |
0 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
|||||
Pituitary gland lesion | Pituitary gland | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
8 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Renal pelvis papilloma | Renal pelvis |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Skin squamous cell carcinoma | Skin | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.3 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Stomach lesion | Stomach | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
12 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Thyroid gland adenoma | Thyroid gland |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Thyroid gland lesion | Thyroid gland | N-ethyl-N-nitrosourea (N-nitrosoethylurea) (ENU) |
7 |
References: Buzard GS, J Cancer Res Clin Oncol 1999 Dec;125(12):653-9 |
||||
Ureter transitional cell carcinoma | Ureter |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Uterus adenoma | Uterus |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Uterus adenoma | Uterus | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
0 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus adenoma | Uterus | sodium arsenite |
4.3 - 4.8 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus adenoma | Uterus | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
4.5 - 4.8 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus hyperplasia - cystic | Uterus |
25 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Uterus hyperplasia - cystic | Uterus | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
29 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus hyperplasia - cystic | Uterus | sodium arsenite |
61 - 67 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus hyperplasia - cystic | Uterus | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
68 - 71 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus lesion | Uterus |
25 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||||
Uterus lesion | Uterus | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
29 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus lesion | Uterus | sodium arsenite |
65 - 71 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
Uterus lesion | Uterus | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
73 - 76 |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
(Unspecified organ) adenoma | (Unspecified organ) | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
(Unspecified organ) tumor | (Unspecified organ) | 12-O-tetradecanoylphorbol-13-acetate (TPA) |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
(Unspecified organ) tumor | (Unspecified organ) |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
||||
(Unspecified organ) tumor | (Unspecified organ) | sodium arsenite |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |
|||
(Unspecified organ) tumor | (Unspecified organ) | sodium arsenite ⋅ 12-O-tetradecanoylphorbol-13-acetate (TPA) |
observed |
observed |
References: Waalkes MP, Carcinogenesis 2004 Jan;25(1):133-41 |